Products Markets Manufacturing Services Blog Who We Are Investor Relations English Home » Investor Relations » Corporate Governance Corporate Governance Your trusted and focused solution partner since 1923 Share Ticker Elos Medtech B (ELOS B) Latest +/- % Ask Bid 304 -16 -5.00 304 301 Last update: 4 December 2021, 9:22 This post is also available in: Svenska According to Elos Medtech's Articles of Association, the Board shall consist of a minimum of three and a maximum of five members. In accordance with the provisions of the Swedish Companies Act, the Board establishes a work procedure each year containing instructions regarding the distribution of work within the Board, distribution of responsibility between the Board and the President and the financial reporting to the Board. During a fiscal year, in addition to the statutory meeting, the Board has six ordinary meetings. At these meetings, the Board addresses points specified for each meeting such as the current status of business, the budget, year-end financial statements and interim reports. In addition, issues such as investments, structural and organizations changes are addressed. Within the Board, there is an Audit Committee. The Audit Committee's work consists of dealing with questions concerning accounting, financing, internal control, risk management and IT security. The Board has chosen not to set up a remuneration committee, but these issues have been handled by the entire Board under the Chair's leadership and following preparation by the Chair. Corporate Governance Code Elos Medtech AB is a Swedish limited liability company, whose Series B share is listed on the NASDAQ Stockholm AB Small Cap. Corporate governance at Elos Medtech is based on Swedish legislation and the listing agreement with NASDAQ Stockholm AB. Elos Medtech is governed via the general meetings of shareholders, the Board of Directors and the President in accordance with the Swedish Companies Act and the company’s Articles of Association and rules of procedure. From 1 July 2008, it is good practice in the stock market for all companies whose shares are registered for trading on a regulated market to apply the Swedish Corporate Governance Code. Such application has been introduced at Elos Medtech AB and this is further described in Corporate Governance Report in the Annual Report. Nomination Committee 2022 The Nomination Committee for the Annual General Meeting 2022: • Lovisa Lander, appointed by Goldcup 27911 AB (TA Associates) • Thomas Öster, appointed by family Öster (incl. companies) • Kent Molin, appointed by family Molin • Jonas Fridh, appointed by Bank Julius Baer & Co LTD Chairman of the Nomination Committee is Lovisa Lander. Chairman of the Board, Yvonne Mårtensson, is adjunct to the Nomination Committee. Shareholders who wish to submit proposals to the Nomination Committee should e-mail to valberedning@elosmedtech.com or send mail to: The Nomination Committee, Elos Medtech AB, Torsgatan 5B, 411 04 Gothenburg, Sweden. For further information please see the pressrelease - Elos Medtech Nomination Committee 2022 Corporate Governance Reports Corporate Governance Report 2020 [ENGLISH] Corporate Governance Report 2019 [ENGLISH] Corporate Governance Report 2018 [ENGLISH] Corporate Governance Report 2017 [SWEDISH] Corporate Governance Report 2016 [SWEDISH] Corporate Governance Report 2015 Corporate Governance Report 2014 Corporate Governance Report 2013 CALENDAR Feb 24, 2022 Year-end Report 2021 April, 2022 Annual Report 2021 April 26, 2022 Interim Report Q1, 2022 May 3, 2022 Annual General Meeting 2022 Aug 18, 2022 Interim Report Q2, 2022 Oct 21, 2022 Interim Report Q3, 2022 Feb 23, 2023 Year-end Report 2022 PRESS RELEASES & REGULATORY INFORMATION Notice to attend the Extraordinary General Meeting of Elos Medtech AB (publ) 29 Nov 2021, 16:30 Elos Medtech Interim Report January 1 - September 30, 2021 20 Oct 2021, 08:00 Elos Medtech Nomination Committee appointed for the 2022 Annual General Meeting 27 Sep 2021, 11:30 PRESS RELEASES & REGULATORY INFORMATION Notice to attend the Extraordinary General Meeting of Elos Medtech AB (publ) 29 Nov 2021, 16:30 Financial / IR information STAY UPDATED! Subscribe to our newsletter SUBSCRIBE Copyright © 2021 by Elos Medtech AB. All rights reserved. Cookies & Privacy Policy Follow us: This website uses cookies to provide you with the best browsing experience. Find out more or adjust your settings. Accept